Base editor screens for in situ mutational scanning at scale

NZ Lue, BB Liau - Molecular Cell, 2023 - cell.com
A fundamental challenge in biology is understanding the molecular details of protein
function. How mutations alter protein activity, regulation, and response to drugs is of critical …

CRISPR applications in cancer diagnosis and treatment

M Wang, M Chen, X Wu, X Huang, B Yu - Cellular & Molecular Biology …, 2023 - Springer
Cancer remains a significant global health challenge, necessitating the exploration of novel
and more precise therapeutic options beyond conventional treatments. In this regard …

[HTML][HTML] Protein post-translational modifications: A key factor in colorectal cancer resistance mechanisms

B Bi, M Qiu, P Liu, Q Wang, Y Wen, Y Li, B Li… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Colorectal cancer (CRC) is one of the leading causes of cancer-related death. Despite
advances in treatment, drug resistance remains a critical impediment. Post-translational …

Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput

PH Kennedy, A Alborzian Deh Sheikh, M Balakar… - Nature …, 2024 - nature.com
Signaling pathways that drive gene expression are typically depicted as having a dozen or
so landmark phosphorylation and transcriptional events. In reality, thousands of dynamic …

[HTML][HTML] ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition

J Yan, W Duan, Q Gao, T Mao, M Wang, J Duan… - Pharmacological …, 2023 - Elsevier
In our previous multicenter study, we delineated the inherent metabolic features of colorectal
cancer (CRC). Therein, we identified a member of the ectonucleotide pyrophosphatase …

Preclinical Anticipation of On-and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review

PJ Dziubańska-Kusibab, E Nevedomskaya… - International Journal of …, 2024 - mdpi.com
The advent of targeted therapies has led to tremendous improvements in treatment options
and their outcomes in the field of oncology. Yet, many cancers outsmart precision drugs by …

Targeting EGFR activation to overcome gemcitabine resistance in cholangiocarcinoma

S Kidoikhammouan, W Lert-Itthiporn… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: Chemotherapy resistance is an important problem in the treatment of
patients with cholangiocarcinoma (CCA) who are not eligible for surgery. This study aimed …

[HTML][HTML] Longitudinal phosphoproteomics reveals the PI3K-PAK1 axis as a potential target for recurrent colorectal liver metastases

D Gunji, Y Abe, S Muraoka, R Narumi, J Isoyama… - Cell Reports, 2024 - cell.com
The resistance of colorectal cancer liver metastases (CRLMs) to 5-fluorouracil (5-FU)
chemotherapy remains a significant global health challenge. We investigated the …

Exploring mechanisms of action in combinatorial therapies through solubility alterations: Advancing AML treatment

E Gholizadeh, E Zangene, U Vadadokhau, D Ritz… - bioRxiv, 2024 - biorxiv.org
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis.
Although treatments like allogeneic hematopoietic stem cell transplantation and high-dose …

Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors

X Zhou, J Gao, L Luo, C Huang, J Wu… - Communications …, 2024 - nature.com
Base editors enable the direct conversion of target bases without inducing double-strand
breaks, showing great potential for disease modeling and gene therapy. Yet, their …